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Interventional radiologyAbstract Purpose: Thepurpose is todescribe and evaluate the techniqueof prophylactic balloonocclu-
sion of the anterior division of the internal iliac arteries (hypogastric arteries) in abnormal placentation.
Materials and methods: It is a retrospective study; the records of 44 patients with a diagnosis of placenta
previa/accreta/percreta were retrospectively reviewed. Patients were divided into two groups. Thirty-two
patients underwent prophylactic temporary balloon occlusion, followed by cesarean section. A review of
cases was done over a period of 5 years. All cases after previous arrangement with the interventional radi-
ologist and after admission, patient in the balloon occlusion group underwent the procedure of hypogas-
tric artery balloon occlusion under ﬂuoroscopy using minimal radiation exposure. Intra-operatively, the
balloon was inﬂated as needed. Twelve patients underwent cesarean section without endovascular inter-
vention. The following parameters were compared in the two groups: patient age, gravidity, parity, gesta-
tional age at delivery, pregnancy outcome, and days in the intensive care unit after delivery, total hospital
days, volume of transfused blood products, operating room time, estimated blood loss, and postoperative
morbidity and mortality.
Results: Patients in the balloonocclusion grouphad signiﬁcantly less in estimated blood loss than thenon
balloon occlusion group. There was no statistical difference in mean volume of replaced blood products,
operating room time or postoperative recovery time.
752 H.S. Darwish et al.Conclusion: Our results support that in patients with placenta accreta/percreta, pre-operative prophylac-
tic temporaryballoonocclusiondiminishes intra-operativeblood loss.Weconclude thatballoonocclusion
of the hypogastric arteries is safe and effective in an attempt to minimize blood loss in patients with
abnormal placentation.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.1. Introduction
Abnormal attachment of the placenta to the myometrium may
occur when there is a deﬁciency of the decidua and when there
is myometrial invasion by chorionic villi (1). There are three
entities (accreta, increta, and percreta) that are deﬁned by
the histological degree of placental invasion into the myome-
trium (2).
The incidence of placenta accreta is highly variable, with
rates reported in the literature ranging from less than
1:700,000–1:500 pregnancies (3).
Risk factors for placenta accreta include placenta previa,
previous cesarean deliveries, multiparity, advanced maternal
age, and prior dilation and curettage (3,4).
Patients with placenta accreta are at a signiﬁcant risk of
maternal and/or fetal mortality, massive blood loss, dissemi-
nated intravascular coagulation and infection (5). Obstetric
hemorrhage from placenta accreta is associated with a high
rate of maternal morbidity and mortality (6).
In developed countries such as the United States, maternal
death rate is 9–17 deaths per 100,000 deliveries compared with
400 deaths per 100,000 deliveries worldwide. The greatest
majority of the deaths in non developed countries were related
to postpartum hemorrhage (PPH). PPH is a leading contributor
to morbidity rather than mortality in the United States whereas
pulmonary embolus is the leading cause of mortality (7).
Antepartum diagnosis is important to allow time to prepare
for the potentially lethal complications associated with abnor-
mal placentation (8).
Antepartum diagnosis is critical to prevent life-threatening
hemorrhage (6). Pelvic ultrasound and MRI provide a means
for antepartum diagnosis and treatment planning (6–8,9).
Because placenta accreta is not always diagnosed early in
patients, conservative treatment includes dilation and curet-
tage and subsequent arterial embolization (10) The current
treatment for third trimester hemorrhage due to abnormal pla-
cental attachment, is a cesarean hysterectomy, which may be
complicated by a large volume of blood loss (11). This bleeding
is usually treated surgically by bilateral hypogastric or uterine
artery ligation (4).
The goal of treatment for all causes of post partumhemorrhage
(PPH) is cessation of bleeding in a timely fashion, before the onset
of consumptive coagulopathy and end organ damage (12).
Recently, balloon occlusion catheters have been used to
control intraoperative bleeding during the surgical manage-
ment of placenta accreta in patients at high risk of peripartum
hemorrhage (6–13).
We report 44 patients with the antenatal diagnosis of pla-
centa previa/accreta/percreta, 32/44 had prophylactic place-
ment of balloon occlusion catheters in the hypogastric
arteries, to minimize blood loss before cesarean delivery, and
12/44 without balloon- occlusion.2. Materials and methods
A review of the computerized data base records of 32 patients
with a diagnosis of placenta previa/accreta/percreta was done
over a period of 5 years (1 March 2008–30 February 2013).
These patients underwent prophylactic temporary balloon
occlusion, followed by cesarean section.
2.1. Approval of the study was obtained from the SFH
Institutional Review Board (IRB)
During the same period of time a control group of 12 patients
underwent cesarean section without endovascular intervention.
After admission of patients and because of high probability of
major intra-partum hemorrhage and the potential for cesarean
hysterectomy, high risk consents were obtained for that, and for
other modalities of treatment, whether medical, surgical or both.
Particular attention was taken to ensure minimal fetal radi-
ation exposure, by the use of appropriate shielding and inter-
mittent low dose ﬂuoroscopy. Total ﬂuoroscopy time ranged
from 0.5 to 3.14 min.
2.1. Procedure
Seldinger technique was used to introduce the catheter into the
vascular system, by making bilateral punctures of femoral
arteries, followed by internal iliac artery catheterization via
contra-lateral approach.
– The technique involved bilateral femoral arterial punctures
and insertion of 6-French vascular sheaths under local anes-
thesia (Fig. 1a).
– Over a 0.035-inch angled guidewire (Flow Directed Balloon
Catheter, Cook), a 5-French cobra-shaped catheter (Cobra,
Terumo) was used to cannulate the contralateral internal
iliac artery. This was exchanged for a 5.5-French occlusion
balloon catheter (Starterwire, Boston Scientiﬁc), which was
positioned with its tip in the proximal portion of the contra-
lateral internal iliac artery, just after the common iliac
artery bifurcation (Fig. 1b).
– Once both balloon catheters were correctly positioned, a
test volume of dilute water-soluble contrast material was
injected to inﬂate the occlusion balloons to the optimal size.
– Once positioning was satisfactory, the catheters were
securely taped to the skin.
– The occlusion balloons were inﬂated at the time immedi-
ately after the baby was delivered, and the umbilical cord
was clamped so as to minimize the risk of fetal ischemia.
– In those who underwent hysterectomy or had the placentas
delivered, the balloons were deﬂated just before skin closure
after ensuring that hemostasis within the pelvic cavity was
secured.
Fig. 1 (a) Flow Directed Balloon Catheter, Cook that was used to cannulate the contralateral internal iliac artery. (b) A 5.5-French
occlusion balloon catheter that was positioned with its tip in the proximal portion of the contralateral internal iliac artery just after the
common iliac artery bifurcation.
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were left inﬂated until embolization was performed.
– The vascular sheaths were left in situ for 24 h after surgery,
with a view for emergency embolization in the event of
severe postpartum hemorrhage.
– Slow continuous normal saline infusion (10 mL/h) through
the sheaths was used to maintain patency of the sheaths
without the use of heparin or anticoagulants.
– After removal of the sheaths, ﬁrm manual compression over
the insertion site was performed for at least 20 min in all
cases. No closure devices were used.2.3. Statistical analysis
Data were analyzed using commercially available software
(statistical package for social sciences, SPSS version 17).
Chart review of all 44 patients was performed. The two
groups were compared with regard to the following variables:
patient age, gravidity, parity, gestational age at delivery, preg-
nancy outcome, days in the ICU after delivery, total hospital
days, volume of transfused blood products (packed red blood
cells), operating room time, estimated blood loss, and postop-
erative morbidity and mortality.
The statistical comparison of mean of previously mentioned
variables of two groups was done using SPSS version 17, two
samples, and T-test. p-Values less than 0.05 were considered
statistically signiﬁcant.
3. Results
The study compares two nonrandomized groups of patients.
Demographic data of both 2 groups are presented in Tables
1 and 2.In the balloon- occlusion group, the ages ranged 27–
42 years with an average of 33.8 years and an average parity
of 2.
The patients in the same group had previous 1–4 cesarean
sections. Only 6 patients had no previous cesarean deliveries.
Twenty-two of thirty-two patients had preexisting medical
problems mainly diabetes mellitus, hypertension and protein
S, gestational diabetes and epilepsy and low vitamin B12 level.
The outcome of pregnancy in the balloon- occlusion group
was 15 boys and 17 girls, with an average weight of 2.74 kg and
an APGAR score of 7 at 1 min and score of 9 at 5 min.
In the control group the patients had previous 1–3 cesarean
sections and 4 patients had no previous cesarean sections.
The outcome of pregnancy in this group was 4 boys and 8
girls with an average weight of 2.46 kg and an APGAR score
of 5 at one minute and 9 at 5 min.
On the basis of gray-scale (Fig. 2a) and color Doppler ultra-
sound examinations (Fig. 2b) performed in the second or third
trimester, placenta previa was detected in all 44 patients and,
therefore, all patients were scheduled for cesarean section and
possible hysterectomy. Gray-scale and color Doppler ultra-
sound suggested the presence of placenta accreta/percreta in
28 of 32 patients in the group treated with balloon- occlusion
of hypogastric arteries, and suggested the presence of placenta
accreta/percreta in 5 of 12 patients in the group treated without
balloon- occlusion of hypogastric arteries.
The MRI study (Fig. 3) was done only in 5 patients out of
32 patients of the ﬁrst group while it was done in 2 patients of
the control group.
At the time of delivery, placenta accreta/percreta was
identiﬁed in all 28 patients diagnosed with US and also in
another 2 from the remaining 4 patients that were normal in
the US study. With histo-pathological assessment, the 2 cases
were focal accreta.
Table 1 Demographic data of the balloon occlusion group.
Patient No. Maternal
age (years)
Gravida/Para Gestational
age (weeks)
Previous
C.S.
1 39 6/3 36 2
2 35 4/1 35 1
3 34 3/2 37 2
4 27 2/1 37 1
5 39 6/4 36 3
6 32 4/1 35 1
7 29 3/2 35 2
8 37 5/2 36 2
9 36 2/1 36 0
10 31 2/1 35 0
11 32 3/2 36 1
12 36 4/2 36 2
13 40 5/4 35 3
14 27 3/2 36 1
15 42 6/4 35 4
16 41 4/2 36 2
17 36 2/1 36 0
18 32 2/1 35 1
19 34 3/2 36 2
20 27 3/1 35 0
21 38 5/4 36 4
22 42 5/3 36 2
23 29 3/2 35 2
24 39 5/4 36 3
25 32 4/3 35 2
26 29 3/1 36 1
27 36 4/2 36 2
28 36 2/1 35 1
29 31 2/1 36 0
30 32 3/2 35 2
31 29 3/1 36 0
32 42 5/2 36 2
Mean 33.8 3.6/2 35.6 1.6
C.S., cesarean section.
Table 2 Demographic data of the control group.
Patient Maternal age Gravida/Para Gestational age Previous
No. (years) (weeks) C.S.
1 36 4/3 32 2
2 35 3/1 35 0
3 32 3/2 33 2
4 26 2/1 36 1
5 33 4/2 36 1
6 32 4/1 34 0
7 28 2/1 35 1
8 37 5/2 34 2
9 35 3/1 32 0
10 32 3/1 34 1
11 40 5/3 35 3
12 36 4/2 36 2
Mean 33.5 3.5/1.6 34.3 1.2
C.S., cesarean section.
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ta/percreta were identiﬁed at the time of delivery. The remain-
ing 5 patients were normal in US and at delivery.
Tables 3 and 4 show the clinical data of both groups, the
length of patient hospital stay ranged from 6 to 52 days in
the balloon- occlusion group, with an average of 21.9 days.
This length of stay, because once the patients were diagnosed
as low lying placentae after 32 weeks of gestation, they were
kept in hospital to avoid catastrophic antepartum hemorrhage
with inability to assess the hospital in time, since most of them
lived in distant areas.
The post operative stay period in the same group was
2–16 days, with an average of 7.1 days.
However, in the control group, the length of patient hospi-
tal stay ranged from 17 to 52 days with an average of
33.8 days.
The post operative stay period in the same group was
4–19 days, with an average of 8.4 days this was more than our
routine post operative care, due to extra procedures undertaken
with some patients including and treating complications, includ-
ing wound infection, paralytic illeus, and intestinal obstruction.
In four patients, bladder injury occurred during operation
and required surgical intensive care unit admission and
occurred in 3 out of 12 patients of control.Intraoperatively extra measures were utilized to control or
minimize the amount of blood loss in both groups, in the form
of medical measures like Hemabate was an (prostaglandin F2)
injection, Cytotec (misoprostol) tablets inserted rectally intra
and postoperatively, Factor VII injections and methotrexate
post operatively; other measures were in the form of leaving
part of or the entire placenta in situ if no signs of separation
were noted.
Bakri balloon insertion, internal iliac artery ligation, bilat-
eral tubal ligation and sub and total hysterectomy in only 4
patients were further means taken to save the life of the patient
in the balloon occlusion group. Out of 12 patients of the control
group, 7 patients need sub and total hysterectomy, and 2 of them
underwent bilateral uterine artery ligation (Tables 5 and 6).
The whole placentas or part of it were kept in four patients
(3 patients from the balloon occlusion group and one patient
from the control group), two of them required methotrexate
therapy to help in resolution of placental tissue.
The patients in the control group were delivered at an ear-
lier gestational age than those in the balloon occlusion group
(34.3 vs. 35.6 weeks), and patients in the control group were
hospitalized for a longer period of time than patients in the
balloon- occlusion group (33.8 vs. 21.9 days).
The amount of blood loss was more in the control group
than in the balloon occlusion group (4.7 vs. 2.9 units).
The statistical comparison of the balloon occlusion group
versus the control group is tabulated in Table 7.4. Discussion
Abnormal placentation (accreta, increta, and percreta) has
emerged over uterine atony as the leading indication for peri-
partum hysterectomy (14).
Placenta accreta refers to a placenta that is abnormally
adherent to the uterus, when the placenta invades the myome-
trium, the term placenta increta is used, whereas placenta per-
creta refers to a placenta that has invaded through the
myometrium and serosa, sometimes into adjacent organs, such
as the bladder. The term placenta accreta is often used inter-
changeably as a general term to describe all of these conditions
(15).
Fig. 2 (a) Gray scale ultrasonography displaying anterior placenta previa completely covered the internal os (previa complete centralis).
No clear space seen between the placenta and myometrium. (b) Color Doppler ultrasonography of lower uterine segment showing minimal
color ﬂow toward the previous cesarean scar suggesting placenta accreta. No vascularity of bladder wall seen. At surgery, the bladder was
not involved.
Fig. 3 (a) Sagittal T2W MR image of the same patient revealed complete placenta praevia centralis. (b) Coronal T2W images of same
patient displaying complete placenta praevia centralis. (c) Complete placenta previa centralis. Mild irregularity and ill deﬁnition of the
myometrium related to anterior aspect of the lower uterine segment that may represent placenta accreta. (d) Sagittal T2W MR image. No
invasion of urinary bladder evident with intact hypointense signals.
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mortality related to pregnancy (16). Cesarean hysterectomy
is a deﬁnitive treatment for life-threatening postpartum bleed-
ing of uterine origin that is unresponsive to medical or less
invasive surgical treatments.
This reﬂects the increased proportion of obstetric patients
with prior cesarean deliveries, a known risk factor for placenta
accreta (17). Additional risk factors for abnormal placental
implantation include advanced maternal age, multiparity,
and repeated dilatation and curettage. The three variants of
abnormal placentation are associated with massive hemor-
rhage, which may lead to hypovolemic shock or a disseminated
coagulopathy at delivery; this can cause considerable maternal
morbidity and mortality. Therefore, antepartum recognition of
invasive placentation is important for planning a multidisci-
plinary approach to a safe delivery and minimizing the risks
of postpartum hemorrhage. Preoperative ultrasound with
color Doppler imaging and MRI are used to establish the diag-
nosis of abnormal placentation and guide the clinical manage-
ment, which can lead to more favorable outcomes (18).
Different treatment modalities are applied for peripartum
hemorrhage in abnormal placental invasion. Uterine curettage,
tamponade devices, peripartum hysterectomies, uterine artery
ligation, hypogastric artery ligation, and hypogastric arteryballooning are the examples for the treatment. Hypogastric
artery ballooning becomes very popular worldwide (19).
Recently, prophylactic hypogastric artery occlusion (Figs. 3
and 4) was introduced to reduce intra-operative blood loss in
patients at high risk for peripartum hemorrhage. Alvarez
et al. (13) reported the usefulness of prophylactic hypogastric
artery occlusion without embolization in a small case–control
study among patients at high risk of peripartum hemorrhage
(20).
Occlusion of the hypogastric arteries does not eliminate the
blood ﬂow to the uterus because of the collateral vascular
structures in the pelvis. However, the technique reduces the
pulse pressure distal to the site of occlusion, thus minimizing
blood loss during a hysterectomy (20).
This method helps to reduce blood inﬂow to hypogastric
collaterals, both in the intra and post operative period, at a
time when most blood loss occurs when the surgeon is trying
to avoid hysterectomy, by using different standard facilities
available.
Antepartum recognition of invasive placentation is impor-
tant for planning a multidisciplinary approach to a safe delivery
and minimizing the risks of postpartum hemorrhage (21). Pre-
operative ultrasound with color Doppler imaging and MRI are
used to establish the diagnosis of abnormal placentation and
Table 3 Clinical data of the balloon- occlusion group.
No. Total H. days ICU days H. days after delivery Blood transfusion (units) Morbidity
1 12 0 4 4 Non
2 52 3 10 6 Paralytic ileus
3 27 3 8 2 Paralytic ileus + hematoma
4 32 2 16 2 Fever + wound infection
5 35 3 8 7 Pelvic Hematoma
6 15 1 7 2 Intestinal obstruction
7 14 5 3 1 Non
8 25 1 4 2 Non
9 35 10 8 6 Pelvic Hematoma
10 18 3 7 0 Paralytic ileus
11 20 5 3 1 Non
12 12 3 8 1 Non
13 14 2 4 1 Non
14 8 1 2 1 Non
15 11 3 6 0 Non
16 24 5 6 2 Fever + wound infection
17 30 3 9 3 Non
18 11 4 10 0 Non
19 32 3 12 4 Intestinal obstruction
20 30 2 5 1 Non
21 32 4 10 7 Bladder injury
22 12 2 8 1 Pelvic Hematoma
23 6 0 2 0 Non
24 12 4 10 6 Bladder injury
25 12 1 5 0 Non
26 8 1 2 1 Fever + wound infection
27 20 2 5 2 Non
28 35 4 10 8 Bladder injury
29 26 3 12 2 Paralytic ileus
30 15 2 5 3 Pelvic Hematoma
31 15 5 6 2 Non
32 52 6 14 6 Bladder injury
Mean 21.9 3 7 7.1 2.9
H. days, hospital days; ICU, intensive care unit.
Table 4 Clinical data of the control group.
No. Total H. days ICU days H. days after delivery Blood transfusion (units) Morbidity
1 52 3 10 6 Bladder injury
2 17 2 8 3 Paralytic ileus
3 29 6 8 6 Pelvic hematoma
4 52 4 19 8 Bladder injury + hematoma
5 35 2 4 4 Pelvic Hematoma
6 20 1 8 2 Non
7 24 6 7 6 Intestinal obstruction
8 20 1 4 2 Non
9 35 6 5 8 Bladder injury
10 52 3 11 2 Paralytic ileus
11 20 2 7 4 Non
12 50 4 10 6 Pelvic hematoma
Mean 33.8 3.3 8.4 4.7
H. days, hospital days; ICU, intensive care unit.
756 H.S. Darwish et al.guide the clinical management, which can lead to more favor-
able outcomes (18).
The diagnosis of abnormal placentation is established by
ultrasonography and occasionally supplemented by magnetic
resonance imaging (MRI).The sonographic features suggestive of placenta accreta
include irregularly shaped placental lacunae (vascular spaces)
within the placenta, thinning of the myometrium overlying the
placenta, loss of the retroplacental ‘‘clear space’’, protrusion
of the placenta into the bladder, increased vascularity of the
Table 5 Intra-operative data of the balloon occlusion group.
No. OR time (min) EBL (l) OR procedure
1 210 1.5 Balloon occlusion + C.S.
2 405 2.5 Balloon occlusion + C.S. + hysterectomy
3 220 1.0 Balloon occlusion + C.S.
4 210 1.0 Balloon occlusion + C.S.
5 338 2.5 Balloon occlusion + C.S. + hysterectomy
6 200 1.0 Balloon occlusion + C.S.
7 210 1.0 Balloon occlusion + C.S.
8 215 1.5 Balloon occlusion + C.S.
9 280 2.5 Balloon occlusion + C.S. + hysterectomy
10 200 0 Balloon occlusion + C.S.
11 225 1.0 Balloon occlusion + C.S. + D&C
12 210 1.0 Balloon occlusion + C.S.
13 215 1.5 Balloon occlusion + C.S.
14 200 1.0 Balloon occlusion + C.S.
15 200 1.5 Balloon occlusion + C.S.
16 230 1.5 Balloon occlusion + C.S.
17 230 1.0 Balloon occlusion + C.S. + D&C
18 210 1.0 Balloon occlusion + C.S.
19 200 1.5 Balloon occlusion + C.S.
20 210 1.0 Balloon occlusion + C.S.
21 500 7.0 Balloon occlusion + C.S. + bladder repair
22 200 1.0 Balloon occlusion + C.S.
23 210 0 Balloon occlusion + C.S.
24 308 2.5 Balloon occlusion + C.S. + bladder repair
25 215 1.0 Balloon occlusion + C.S.
26 205 2.0 Balloon occlusion + C.S.
27 210 1.0 Balloon occlusion + C.S.
28 520 8.0 Balloon occlusion + C.S. + hysterectomy + bladder repair
29 210 1.0 Balloon occlusion + C.S.
30 230 1.5 Balloon occlusion + C.S.
31 200 1.0 Balloon occlusion + C.S.
32 410 8.0 Balloon occlusion + C.S. + bladder repair
Mean 250.8 1.9
OR, operating room; EBL, estimated blood loss; C.S., cesarean section; min, minutes; D&C, dilatation and curettage.
Table 6 Intra-operative data of the control group.
No. OR time (min) EBL (l) OR procedure
1 235 3.0 Cesarean hysterectomy + bladder repair
2 120 1.0 Cesarean section
3 215 2.5 Cesarean hysterectomy + reoperation for intraperitoneal bleed
4 160 4.0 Cesarean hysterectomy + bladder repair
5 120 2.0 Cesarean hysterectomy
6 45 1.5 Cesarean section
7 275 3.0 Cesarean hysterectomy + bilateral uterine artery occlusion
8 65 1.0 Cesarean section
9 310 6.0 Cesarean section + bladder repair
10 200 2.0 Cesarean hysterectomy
11 90 2.0 Cesarean section
12 320 6.0 Cesarean hysterectomy + bilateral uterine artery occlusion
Mean 179.5 2.8
OR, operating room; EBL, estimated blood loss; C.S, cesarean section; Min., minutes.
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phy, turbulent blood ﬂow through the lacunae (22).
Thinning of the uterine wall and loss of hypoechoic area
between the placenta and myometrium were found by MRI
in cases of placenta percreta.Baughman et al. (23) described MRI characteristics of pla-
centa accreta; placenta previa, uterine bulging, heterogeneous
signal intensity within the placenta, dark intraplacenta bands
on T2-weighted images, focal interruptions in myometrial wall,
tenting of the bladder, and direct visualization of the invasion
Table 7 Statisical comparison of the balloon occlusion group versus the control group.
Variable Balloon occlusion group (n= 32) Control group (n= 32) P value (T-test)
Maternal age 33.8 33.5 0.664
Gravidity 3.6 3.5 0 .638
Parity 2 1.6 0.275
Gestational age
At delivery (weeks) 35.6 34.3 0.008
ICU days after delivery 3 3.3 0.896
Total inpatient days 21.9 33.8 0.168
Volume of transfused packed
RBCs (units) 2.9 4.7 0.142
OR time (min) 250.8 179.5 0.100
Estimated blood loss 1.9 2.8 0. 019
ICU, intensive care unit; OR, operating room; Min., minutes.
Fig. 4 (a) Pre- operative ﬂuoroscopy of same patient, shows the
endovascular bilateral inﬂated internal iliac artery balloons. (b)
Fluoroscopic image after cesarean delivery of same patient shows
bilateral inﬂated internal iliac artery balloons.
758 H.S. Darwish et al.of pelvic structures by placenta tissues. Sonography is the pri-
mary imaging modality for diagnosing accreta. However, when
there is a posterior placenta accreta, ultrasonography may be
less than adequate, and MRI may be superior to ultrasonogra-
phy for this speciﬁc indication (22–24).
In our series, high suspicion of placenta accreta/percerta was
documented sonographically in 28/32 cases (87.5%) in the
group treated with balloon- occlusion of hypogastric arteries
(Fig. 4), and suggested in only 7/12 cases (58.3%) in the group
treated without balloon- occlusion of hypogastric arteries.
This result is much less than the 100% suspicious of
placenta previa in the Kidney et al. series (20), which might
reﬂect the difference in ultrasound experience between the
two institutes. In spite of ultrasound expert diagnosis, there
was an error rate of 40% after histopathology studies in the
same study.
In our series, only in 15 cases (34%) histology specimens
were sent to the laboratory, probably due to the fact that the
placenta was separated easily or because it was left in situ
and sloughed off gradually in pieces.
The total ﬂuoroscopy time ranged from 0.5 to 3.14 min, the
average fetal radiation time which is the total ﬂuoroscopy
time, was much less, 1.5 min in our series in comparison to
5.8 min. in the Kidney series (20) and 4.2 min. in Bonder
et al. study (11). This may be due to the adoption of intermit-
tent method of ﬂuoroscopy in our institute.According to the National Radiological Protection Board
of the United Kingdom, the risk barely exceeds the threshold
for diagnostic studies (25).
Intra-operative blood loss, the average blood loss in the
balloon- occlusion group was 1900 ml which is more in the
control group; the average is 2800 ml which was statistically
signiﬁcant.
The amount of blood transfused was more in our series 2.9
units in the balloon occlusion group and 4.7 units in the con-
trol group, in comparison to that of Kidney’s who had an
average of 1.8 units transfusion rate per patient. In the Kidney
series hysterectomy was done in all patients.
Postoperative hospital stay was longer in our series with an
average of 7.1 and 8.4 days in the balloon occlusion group and
control group respectively, vs. 4 days in the Kidney series,
probably because of the differences of the management.
In our series complication includes paralytic illus and intes-
tinal obstruction (18%), the wound infection was seen in about
10%, while the most serious complication, the bladder injury
was seen in 4 cases (12%) in the balloon occlusion group.
While in the control group, paralytic illus and intestinal
obstruction was seen in 3/12 cases (25%) and bladder injury
was seen in 3/12 cases (25%).
Cystotomy was reported in 40% of cases of Kidney series
(bladder invasion by placenta) but did not occur in our studied
patients.
In our study we found that the mean blood loss and trans-
fusion requirements during hysterectomy were signiﬁcantly
decreased in patients who had the procedure, compared to
those who did not. However, some other studies have shown
conﬂicting results concerning the efﬁcacy of prophylactic
hypogastric artery ballooning; some have reported satisfactory
outcomes for decreasing the mean blood loss and transfusion
requirements (20–26), and others have reported no beneﬁt
(17–27).5. Conclusion
Preoperative placement of internal iliac artery occlusion bal-
loons is a safe and minimally invasive technique that reduces
the intra-operative blood loss and transfusion requirements
of patients with placenta accreta and its variants undergoing
cesarean delivery.
Prophylactic preoperative balloon occlusion of hypogastric arteries 759This procedure is associated with a shorter duration of
cesarean surgery, with no signiﬁcant increase in the duration
of ICU stay or hospitalization.
However, further studies are needed for a more detailed
outcome, side effects and to determine whether the potential
beneﬁts of prophylactic hypogastric artery occlusion outweigh
the potential risks associated with fetal radiation exposure and
vascular complications. Team work and early collaboration
are mandatory in these cases.
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